PubRank

Anton Vonk-Noordegraaf

Author PubWeight™ 105.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation 2013 3.90
2 Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007 3.87
3 Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011 3.69
4 Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 2008 2.73
5 Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 2007 2.68
6 Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med 2012 2.52
7 Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med 2015 2.23
8 Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006 2.12
9 Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol 2008 1.97
10 Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. Chest 2007 1.74
11 Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension. Eur Respir J 2012 1.55
12 Correction of phase offset errors in main pulmonary artery flow quantification. J Magn Reson Imaging 2005 1.51
13 Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension. Eur Respir J 2013 1.50
14 Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol 2012 1.48
15 Cardiac function and position more than 5 years after pneumonectomy. Ann Thorac Surg 2007 1.44
16 Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2005 1.43
17 Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension. J Cardiovasc Magn Reson 2010 1.42
18 Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 2013 1.35
19 Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 2008 1.31
20 Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail 2011 1.30
21 Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest 2004 1.26
22 A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 2005 1.22
23 Rapid quantification of myocardial fibrosis: a new macro-based automated analysis. Cell Oncol (Dordr) 2011 1.22
24 Impaired stroke volume response to exercise in pulmonary arterial hypertension. J Am Coll Cardiol 2006 1.18
25 Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure. Chest 2010 1.18
26 Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 2007 1.13
27 Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet 2013 1.11
28 Selective diaphragm muscle weakness after contractile inactivity during thoracic surgery. Ann Surg 2011 1.09
29 Accurate assessment of load-independent right ventricular systolic function in patients with pulmonary hypertension. J Heart Lung Transplant 2012 1.08
30 Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol 2011 1.07
31 Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? Am Heart J 2007 1.06
32 Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure. Am J Respir Crit Care Med 2010 1.05
33 Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization. Circ Heart Fail 2011 1.02
34 Cardiopulmonary exercise testing reveals onset of disease and response to treatment in a case of heritable pulmonary arterial hypertension. Pulm Circ 2012 1.00
35 Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. Eur Heart J 2011 1.00
36 Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart. Am J Physiol Heart Circ Physiol 2009 1.00
37 Interventricular septal configuration at mr imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 2005 0.98
38 Early onset of retrograde flow in the main pulmonary artery is a characteristic of pulmonary arterial hypertension. J Magn Reson Imaging 2011 0.96
39 Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2009 0.95
40 Diaphragm muscle fiber weakness in pulmonary hypertension. Am J Respir Crit Care Med 2010 0.95
41 Improved ECG detection of presence and severity of right ventricular pressure load validated with cardiac magnetic resonance imaging. Am J Physiol Heart Circ Physiol 2008 0.95
42 Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration 2007 0.94
43 Early changes in rat hearts with developing pulmonary arterial hypertension can be detected with three-dimensional electrocardiography. Am J Physiol Heart Circ Physiol 2007 0.93
44 Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe? Am J Respir Crit Care Med 2012 0.93
45 Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress. J Cardiovasc Magn Reson 2012 0.91
46 Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD. Pulm Pharmacol Ther 2008 0.91
47 Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension. Chest 2012 0.91
48 Proportional Relations Between Systolic, Diastolic and Mean Pulmonary Artery Pressure are Explained by Vascular Properties. Cardiovasc Eng Technol 2010 0.91
49 Rapid quantification of myocardial fibrosis: A new macro-based automated analysis. Anal Cell Pathol (Amst) 2010 0.90
50 Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mucosa in high risk patients. Lung Cancer 2003 0.88
51 Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension. Circulation 2005 0.87
52 Risk factors for hemoptysis in idiopathic and hereditary pulmonary arterial hypertension. PLoS One 2013 0.87
53 Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol 2009 0.86
54 The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension. Am J Respir Crit Care Med 2015 0.86
55 Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension. Clin Cardiol 2013 0.85
56 Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction. Am J Physiol Lung Cell Mol Physiol 2012 0.85
57 Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2. Chest 2015 0.85
58 Successful treatment of diffuse pulmonary lymphangiomatosis with bevacizumab. Ann Intern Med 2012 0.84
59 Non-invasive stroke volume assessment in patients with pulmonary arterial hypertension: left-sided data mandatory. J Cardiovasc Magn Reson 2008 0.83
60 Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study. Arthritis Res Ther 2011 0.83
61 Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension. Int J Rheumatol 2010 0.83
62 Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition. Congenit Heart Dis 2008 0.83
63 Prognostic relevance of changes in exercise test variables in pulmonary arterial hypertension. PLoS One 2013 0.82
64 Pulmonary vascular responses to hypoxia and hyperoxia in healthy volunteers and COPD patients measured by electrical impedance tomography. Chest 2003 0.82
65 Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. Eur Respir J 2013 0.82
66 Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension. J Heart Lung Transplant 2012 0.82
67 Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J 2013 0.82
68 Prolonged right ventricular post-systolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction. Heart 2010 0.81
69 Pulmonary 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertension. Pulm Circ 2013 0.81
70 The shrinking heart in chronic obstructive pulmonary disease. N Engl J Med 2010 0.80
71 Addition of prostanoids in pulmonary hypertension deteriorating on oral therapy. J Heart Lung Transplant 2009 0.80
72 Reversibility of the monocrotaline pulmonary hypertension rat model. Eur Respir J 2013 0.79
73 The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload. Int J Cardiovasc Imaging 2013 0.79
74 TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension. J Med Genet 2013 0.79
75 Reduced systemic oxygen extraction does not prove muscle dysfunction in PAH. Med Sci Sports Exerc 2008 0.79
76 Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension. Rheumatology (Oxford) 2013 0.79
77 Reduced mechanical efficiency of rat papillary muscle related to degree of hypertrophy of cardiomyocytes. Am J Physiol Heart Circ Physiol 2010 0.79
78 Modeling the instantaneous pressure-volume relation of the left ventricle: a comparison of six models. Ann Biomed Eng 2009 0.79
79 A 31-year-old man with hemoptysis at high altitude and abnormal hepatic biochemistry tests. Chest 2007 0.79
80 Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension. Eur J Heart Fail 2011 0.78
81 Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study. Respir Res 2008 0.78
82 Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition. Eur Respir J 2013 0.78
83 Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension. Heart 2011 0.78
84 Estimation of three- and four-element windkessel parameters using subspace model identification. IEEE Trans Biomed Eng 2010 0.77
85 Pulmonary arterial hypertension combined with a high cardiac output state: Three remarkable cases. Pulm Circ 2013 0.77
86 Unusual manifestation of Riedel's thyroiditis. Ann Thorac Surg 2007 0.77
87 Exercise stroke volume and heart rate response differ in right and left heart failure. Eur J Heart Fail 2010 0.76
88 Predicting pulmonary hypertension with standard computed tomography pulmonary angiography. Int J Cardiovasc Imaging 2015 0.76
89 Cardiac phase-dependent time normalization reduces load dependence of time-varying elastance. Am J Physiol Heart Circ Physiol 2008 0.76
90 Pulmonary function and exercise testing in adult survivors of congenital diaphragmatic hernia. Pediatr Pulmonol 2007 0.76
91 Gene expression profile in the diaphragm following contractile inactivity during thoracic surgery. Int J Physiol Pathophysiol Pharmacol 2011 0.76
92 Echocardiography is not sufficient to diagnose pulmonary arterial hypertension in systemic sclerosis: comment on the article by Wigley et al. Arthritis Rheum 2006 0.75
93 Interventricular mechanical dyssynchrony in pulmonary arterial hypertension: early or delayed strain in the right ventricular free wall? Am J Cardiol 2009 0.75
94 Author's reply. Pulm Circ 2013 0.75
95 Smallest detectable change in volume differs between mass flow sensor and pneumotachograph. BMC Res Notes 2011 0.75
96 Early-diastolic left ventricular lengthening implies pulmonary hypertension-induced right ventricular decompensation. Cardiovasc Res 2012 0.75
97 Myocardial oxygen extraction fraction measured using bolus inhalation of 15O-oxygen gas and dynamic PET. J Nucl Med 2010 0.75
98 Spirometry in chronic obstructive pulmonary disease: a hemodynamic roller coaster? Am J Respir Crit Care Med 2012 0.75
99 Stroke volume response during exercise measured by acetylene uptake and MRI. Physiol Meas 2006 0.75
100 [Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology]. Turk Kardiyol Dern Ars 2014 0.75
101 Low complication rates with totally implantable access port use in epoprostenol treatment of pulmonary hypertension. J Heart Lung Transplant 2009 0.75
102 The Authors Reply. JACC Cardiovasc Imaging 2016 0.75
103 Epoprostenol in pulmonary arterial hypertension. Expert Opin Drug Metab Toxicol 2009 0.75
104 Left ventricular encasement after pneumonectomy: case report. J Thorac Cardiovasc Surg 2006 0.75
105 Assessment of the pulmonary volume pulse in idiopathic pulmonary arterial hypertension by means of electrical impedance tomography. Respiration 2005 0.75
106 Fluid therapy in critically ill patients: perspectives from the right heart. Anaesthesiol Intensive Ther 2015 0.75
107 Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation. J Card Fail 2011 0.75